Who owns VERTEX PHARMACEUTICALS INC / MA (VRTX)? Elite investor 13F holders

7 tracked elite investors reported holding VERTEX PHARMACEUTICALS INC / MA as of 2026-09-30, including Renaissance Technologies LLC, Tweedy Browne, Bridgewater Associates, Gotham Asset Management, D.E. Shaw. Who bought, trimmed or exited each quarter, with links to the original SEC 13F filings.

7 tracked investors currently reported holding · Latest report period: 2026-09-30 · Health Care · Pharmaceuticals, Biotechnology & Life Sciences

Vertex Pharmaceuticals Incorporated operates as a biotechnology company in the United States, Europe, and internationally. The company offers transformative medicines for people with serious diseases with a focus on specialty markets, such as cystic fibrosis (CF), sickle cell disease (SCD), transfusion dependent beta thalassemia (TDT), and acute pain. It markets TRIKAFTA/KAFTRIO for people with…

Reported holders and securities, including exits (up to 20)

Reported holders and securities, including exits (up to 20)
InvestorSecurityInstrumentReport periodFiledValueQuantityUnitsChangeSource
Renaissance Technologies LLCVERTEX PHARMACEUTICALS INCSHARE2026-09-302026-11-12 00:00:00207434278.00 USD396768.000000SharesaddOriginal filing
Tweedy BrowneVERTEX PHARMACEUTICALS INCSHARE2026-09-302026-11-04 00:00:0013599857.00 USD26013.000000SharesreduceOriginal filing
Bridgewater AssociatesVERTEX PHARMACEUTICALS INCSHARE2026-09-302026-11-16 00:00:0018253911.00 USD34915.000000SharesaddOriginal filing
Gotham Asset ManagementVERTEX PHARMACEUTICALS INCSHARE2026-09-302026-11-16 00:00:0017391797.00 USD33266.000000SharesaddOriginal filing
Torray FundsVERTEX PHARMACEUTICALS INCSHARE2026-09-302026-10-30 00:00:000.00 USD0.000000SharesexitedOriginal filing
D.E. ShawVERTEX PHARMACEUTICALS INCSHARE2026-09-302026-11-16 00:00:002943944.00 USD5631.000000SharesaddOriginal filing
Ancora Advisors / Ancora HoldingsVERTEX PHARMACEUTICALS INCSHARE2026-09-302026-11-17 00:00:00658393.00 USD1259.000000SharesaddOriginal filing
GAMCOVERTEX PHARMACEUTICALS INCSHARE2026-09-302026-11-12 00:00:00209124.00 USD400.000000SharesbuyOriginal filing

Public disclosures can be delayed, incomplete, or amended. Report period describes a position date; transaction date describes a reported transaction; filed describes submission. A recent filing or page update does not establish a current holding. A dash means unavailable or not comparable, not zero.

This public summary shows the default reporting scope. Enable JavaScript for interactive filters, charts, and additional rows.

How to read the data · Disclaimer

Read as Markdown